Description

Human Menopausal Gonadotrophin (HMG) is a purified glycoprotein hormone preparation extracted from the urine of postmenopausal women, containing both Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) activity. It is a critical active pharmaceutical ingredient (API) in the development of fertility treatments, directly addressing the need for controlled ovarian stimulation. This product is essential for pharmaceutical manufacturers and research institutions focused on reproductive medicine, hormone therapy, and advanced biopharmaceutical development.

Application

• Fertility Drug Formulation: Primary active ingredient in injectable medications for the treatment of female infertility, including anovulation and assisted reproductive technologies (ART) like in vitro fertilization (IVF).
• Ovarian Stimulation: Used to induce the development of multiple ovarian follicles in women undergoing controlled ovarian hyperstimulation cycles.
• Hypogonadotropic Hypogonadism: Therapeutic agent for the treatment of fertility issues arising from deficient gonadotropin secretion.
• Biopharmaceutical Research: Reference standard and key material in R&D for novel hormone therapies and biosimilar development.
• Clinical Diagnostics: Used in the calibration and validation of diagnostic assays measuring gonadotropin levels.
• Veterinary Reproduction: Applied in advanced reproductive technologies for valuable livestock and endangered species.

Basic Information

Item	Detail
Product Name	Human Menopausal Gonadotrophin
CAS No.	61489-71-2
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Menotropins; HMG; Human Menopausal Gonadotropin; Pergonal (Trade Name); Humegon (Trade Name); Menopur (Trade Name); Urinary-derived FSH/LH; Urofollitropin (related); Follicle-Stimulating Hormone and Luteinizing Hormone combination
EINECS	Contact for details

Quality Control

Our Human Menopausal Gonadotrophin is manufactured and tested under strict quality systems. Each batch is controlled to meet high-purity standards suitable for pharmaceutical applications, with specific activity and impurity profiles rigorously assessed. Certificates of Analysis (COA) documenting identity, purity, potency, and safety (including bioburden and endotoxin levels where applicable) are provided to ensure compliance with cGMP guidelines and customer specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at the recommended temperature (typically 2-8°C for long-term stability). This product is hygroscopic (moisture-sensitive); ensure the container is sealed under controlled humidity conditions to maintain stability and potency.

Specification

Item	Specification
Appearance	White or off-white powder or lyophilized solid
Identification (Bioassay/IR)	Complies
Specific Biological Activity (FSH)	Contact for details
Specific Biological Activity (LH)	Contact for details
Purity (HPLC)	> 95% (or as per grade)
Protein Content	Determined by UV or colorimetric assay
pH (in solution)	6.5 - 7.5
Water Content (K.F.)	< 5.0%
Bacterial Endotoxins	< 5.0 IU/mg (or as per grade)
Sterility (where applicable)	Complies with Ph. Eur./USP

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.